101.00
+5.00
+(5.21%)
At close: January 31 at 8:05:02 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in CNY | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 3 | 32 | 34 |
| Avg. Estimate | 27.16B | 30.27B | 106.02B | 114.92B |
| Low Estimate | 25.54B | 28.7B | 104.09B | 105.28B |
| High Estimate | 28.64B | 32.78B | 109.01B | 124.27B |
| Year Ago Sales | 27.14B | 26.85B | 103.47B | 106.02B |
| Sales Growth (year/est) | 0.09% | 12.73% | 2.46% | 8.40% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NEH.F | -- | -- | -- | -- |
| S&P 500 | 10.32% | 10.05% | 13.98% | 13.74% |
Upgrades & Downgrades
| Maintains | B of A Securities: Buy to Buy | 1/15/2025 |
| Upgrade | Morgan Stanley: Equal-Weight to Overweight | 1/8/2025 |
| Maintains | Citigroup: Buy to Buy | 11/15/2024 |
| Maintains | Benchmark: Buy to Buy | 11/15/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 8/26/2024 |
| Maintains | B of A Securities: Buy to Buy | 8/23/2024 |